Similar Stories to Why Sarepta Therapeutics Stock Is Blasting Higher Today on Bing News

Shares of rare disease specialist Sarepta Therapeutics (NASDAQ: SRPT) rose by as much as 67.7% today on over ten times the average daily volume. What sent this mid-cap biotech stock into orbit?This monstrous rally was triggered by a positive interim data release for experimental gene therapy AAVrh74.MHCK7.micro-Dystrophin, which is designed to boost the levels of a key functional protein largely absent in the muscles of patients suffering from Duchenne muscular dystrophy (DMD).   Image source: Getty Images.Continue reading

BING NEWS:
  • Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?
    Shares of Sarepta Therapeutics SRPT have soared 43% year to date, significantly outperforming the industry’s 6.9% decline. The stock has also underperformed the sector and the S&P 500 during the ...
    11/28/2024 - 11:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News